nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—RRM1—Synthesis and interconversion of nucleotide di- and triphosphates—NME1—peripheral nervous system neoplasm	0.0158	0.205	CbGpPWpGaD
Fludarabine—POLA1—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.00886	0.624	CbGdCrCtD
Fludarabine—Adenosine triphosphate—ALK—peripheral nervous system neoplasm	0.00573	0.522	CrCbGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.00549	0.0712	CbGpPWpGaD
Fludarabine—RRM1—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00488	0.0633	CbGpPWpGaD
Fludarabine—Adenosine triphosphate—AKT1—peripheral nervous system neoplasm	0.00447	0.407	CrCbGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.00422	0.0548	CbGpPWpGaD
Fludarabine—DCK—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00376	0.0487	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.00309	0.0401	CbGpPWpGaD
Fludarabine—DCK—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.00277	0.195	CbGdCrCtD
Fludarabine—DCK—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.00256	0.18	CbGdCrCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.00238	0.0309	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.00134	0.0174	CbGpPWpGaD
Fludarabine—RRM1—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.00127	0.0165	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.00121	0.0157	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.00117	0.0152	CbGpPWpGaD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.00116	0.0151	CbGpPWpGaD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.00116	0.0151	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00112	0.0145	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.00106	0.0138	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000975	0.0127	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000959	0.0124	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000947	0.0123	CbGpPWpGaD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000868	0.0113	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000833	0.0108	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000821	0.0107	CbGpPWpGaD
Fludarabine—Adenosine triphosphate—ABCB1—peripheral nervous system neoplasm	0.000781	0.0711	CrCbGaD
Fludarabine—DCK—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000729	0.00946	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000713	0.00926	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000682	0.00885	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000658	0.00854	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00064	0.0083	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.0006	0.00778	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000591	0.00768	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.000586	0.0076	CbGpPWpGaD
Fludarabine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000574	0.000639	CcSEcCtD
Fludarabine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000573	0.000638	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000572	0.000638	CcSEcCtD
Fludarabine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000567	0.000631	CcSEcCtD
Fludarabine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000564	0.000628	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000563	0.000627	CcSEcCtD
Fludarabine—Malaise—Etoposide—peripheral nervous system neoplasm	0.000562	0.000626	CcSEcCtD
Fludarabine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000562	0.000626	CcSEcCtD
Fludarabine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000558	0.000622	CcSEcCtD
Fludarabine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000558	0.000621	CcSEcCtD
Fludarabine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000558	0.000621	CcSEcCtD
Fludarabine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000556	0.000619	CcSEcCtD
Fludarabine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000556	0.000619	CcSEcCtD
Fludarabine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000556	0.000619	CcSEcCtD
Fludarabine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000552	0.000615	CcSEcCtD
Fludarabine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000551	0.000614	CcSEcCtD
Fludarabine—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.00055	0.000613	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000549	0.00713	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000549	0.00712	CbGpPWpGaD
Fludarabine—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000548	0.00061	CcSEcCtD
Fludarabine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000547	0.000609	CcSEcCtD
Fludarabine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000547	0.000609	CcSEcCtD
Fludarabine—Rash—Topotecan—peripheral nervous system neoplasm	0.000547	0.000609	CcSEcCtD
Fludarabine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000546	0.000609	CcSEcCtD
Fludarabine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000546	0.000608	CcSEcCtD
Fludarabine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000545	0.000607	CcSEcCtD
Fludarabine—Cough—Etoposide—peripheral nervous system neoplasm	0.000544	0.000606	CcSEcCtD
Fludarabine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000544	0.000606	CcSEcCtD
Fludarabine—Headache—Topotecan—peripheral nervous system neoplasm	0.000543	0.000605	CcSEcCtD
Fludarabine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000542	0.000604	CcSEcCtD
Fludarabine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000542	0.000604	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000542	0.000604	CcSEcCtD
Fludarabine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000542	0.000604	CcSEcCtD
Fludarabine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000542	0.000604	CcSEcCtD
Fludarabine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000542	0.000603	CcSEcCtD
Fludarabine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00054	0.000602	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.00054	0.00701	CbGpPWpGaD
Fludarabine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00054	0.000601	CcSEcCtD
Fludarabine—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.00054	0.000601	CcSEcCtD
Fludarabine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000539	0.0006	CcSEcCtD
Fludarabine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000539	0.0006	CcSEcCtD
Fludarabine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000537	0.000598	CcSEcCtD
Fludarabine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000537	0.000598	CcSEcCtD
Fludarabine—Pain—Vincristine—peripheral nervous system neoplasm	0.000537	0.000598	CcSEcCtD
Fludarabine—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000537	0.000598	CcSEcCtD
Fludarabine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000537	0.000598	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000537	0.00696	CbGpPWpGaD
Fludarabine—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000536	0.000597	CcSEcCtD
Fludarabine—Rash—Melphalan—peripheral nervous system neoplasm	0.000535	0.000596	CcSEcCtD
Fludarabine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000535	0.000596	CcSEcCtD
Fludarabine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00053	0.00059	CcSEcCtD
Fludarabine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000525	0.000584	CcSEcCtD
Fludarabine—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000523	0.000582	CcSEcCtD
Fludarabine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000518	0.000577	CcSEcCtD
Fludarabine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000515	0.000574	CcSEcCtD
Fludarabine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000515	0.000574	CcSEcCtD
Fludarabine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000513	0.000572	CcSEcCtD
Fludarabine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000511	0.000569	CcSEcCtD
Fludarabine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000511	0.000569	CcSEcCtD
Fludarabine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000509	0.000567	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000506	0.000564	CcSEcCtD
Fludarabine—Infection—Etoposide—peripheral nervous system neoplasm	0.000506	0.000563	CcSEcCtD
Fludarabine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000505	0.000562	CcSEcCtD
Fludarabine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000504	0.000562	CcSEcCtD
Fludarabine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000502	0.000559	CcSEcCtD
Fludarabine—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000499	0.000556	CcSEcCtD
Fludarabine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000499	0.000556	CcSEcCtD
Fludarabine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000498	0.000555	CcSEcCtD
Fludarabine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000497	0.000553	CcSEcCtD
Fludarabine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000496	0.000552	CcSEcCtD
Fludarabine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000495	0.000552	CcSEcCtD
Fludarabine—DCK—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000492	0.00639	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000492	0.000548	CcSEcCtD
Fludarabine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000489	0.000544	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000487	0.00632	CbGpPWpGaD
Fludarabine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000485	0.00054	CcSEcCtD
Fludarabine—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000484	0.000539	CcSEcCtD
Fludarabine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000483	0.000538	CcSEcCtD
Fludarabine—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000482	0.000537	CcSEcCtD
Fludarabine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000481	0.000536	CcSEcCtD
Fludarabine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00048	0.000535	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00048	0.000534	CcSEcCtD
Fludarabine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000476	0.000531	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000476	0.00618	CbGpPWpGaD
Fludarabine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000475	0.000529	CcSEcCtD
Fludarabine—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000469	0.000523	CcSEcCtD
Fludarabine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000469	0.000523	CcSEcCtD
Fludarabine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000468	0.000521	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000467	0.00606	CbGpPWpGaD
Fludarabine—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000466	0.000519	CcSEcCtD
Fludarabine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000517	CcSEcCtD
Fludarabine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000463	0.000516	CcSEcCtD
Fludarabine—RRM1—Metabolism—GNS—peripheral nervous system neoplasm	0.000462	0.006	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000462	0.006	CbGpPWpGaD
Fludarabine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000461	0.000514	CcSEcCtD
Fludarabine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000458	0.00051	CcSEcCtD
Fludarabine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000457	0.000509	CcSEcCtD
Fludarabine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000454	0.000505	CcSEcCtD
Fludarabine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000453	0.000504	CcSEcCtD
Fludarabine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000452	0.000504	CcSEcCtD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.000451	0.00585	CbGpPWpGaD
Fludarabine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000451	0.000502	CcSEcCtD
Fludarabine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.00045	0.000501	CcSEcCtD
Fludarabine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000447	0.000498	CcSEcCtD
Fludarabine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000446	0.000497	CcSEcCtD
Fludarabine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000446	0.000497	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000443	0.000494	CcSEcCtD
Fludarabine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000443	0.000494	CcSEcCtD
Fludarabine—RRM1—Metabolism—NME1—peripheral nervous system neoplasm	0.000443	0.00575	CbGpPWpGaD
Fludarabine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000442	0.000493	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000441	0.00572	CbGpPWpGaD
Fludarabine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.000491	CcSEcCtD
Fludarabine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.00044	0.00049	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000439	0.000489	CcSEcCtD
Fludarabine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000439	0.000489	CcSEcCtD
Fludarabine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000439	0.000489	CcSEcCtD
Fludarabine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000438	0.000488	CcSEcCtD
Fludarabine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000486	CcSEcCtD
Fludarabine—Pain—Etoposide—peripheral nervous system neoplasm	0.000435	0.000485	CcSEcCtD
Fludarabine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000435	0.000485	CcSEcCtD
Fludarabine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000435	0.000484	CcSEcCtD
Fludarabine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000434	0.000483	CcSEcCtD
Fludarabine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000434	0.000483	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000481	CcSEcCtD
Fludarabine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00043	0.000479	CcSEcCtD
Fludarabine—RRM1—Metabolism—COX2—peripheral nervous system neoplasm	0.000427	0.00554	CbGpPWpGaD
Fludarabine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000426	0.000475	CcSEcCtD
Fludarabine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000422	0.00047	CcSEcCtD
Fludarabine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.00042	0.000467	CcSEcCtD
Fludarabine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000419	0.000467	CcSEcCtD
Fludarabine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000419	0.000466	CcSEcCtD
Fludarabine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000418	0.000465	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	0.000417	0.00541	CbGpPWpGaD
Fludarabine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000416	0.000464	CcSEcCtD
Fludarabine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000415	0.000462	CcSEcCtD
Fludarabine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000411	0.000458	CcSEcCtD
Fludarabine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000411	0.000457	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00041	0.000457	CcSEcCtD
Fludarabine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000409	0.000456	CcSEcCtD
Fludarabine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000408	0.000455	CcSEcCtD
Fludarabine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000453	CcSEcCtD
Fludarabine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000406	0.000452	CcSEcCtD
Fludarabine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000404	0.00045	CcSEcCtD
Fludarabine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.000449	CcSEcCtD
Fludarabine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000402	0.000448	CcSEcCtD
Fludarabine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000402	0.000448	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000402	0.00521	CbGpPWpGaD
Fludarabine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000447	CcSEcCtD
Fludarabine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.0004	0.000445	CcSEcCtD
Fludarabine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000399	0.000445	CcSEcCtD
Fludarabine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000399	0.000444	CcSEcCtD
Fludarabine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000399	0.000444	CcSEcCtD
Fludarabine—Rash—Vincristine—peripheral nervous system neoplasm	0.000396	0.000441	CcSEcCtD
Fludarabine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000396	0.000441	CcSEcCtD
Fludarabine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.00044	CcSEcCtD
Fludarabine—Headache—Vincristine—peripheral nervous system neoplasm	0.000394	0.000438	CcSEcCtD
Fludarabine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.000435	CcSEcCtD
Fludarabine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000388	0.000433	CcSEcCtD
Fludarabine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000387	0.000431	CcSEcCtD
Fludarabine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000387	0.000431	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.00038	0.00493	CbGpPWpGaD
Fludarabine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00038	0.000423	CcSEcCtD
Fludarabine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00038	0.000423	CcSEcCtD
Fludarabine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000375	0.000418	CcSEcCtD
Fludarabine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.000416	CcSEcCtD
Fludarabine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000373	0.000416	CcSEcCtD
Fludarabine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000414	CcSEcCtD
Fludarabine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.000412	CcSEcCtD
Fludarabine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000411	CcSEcCtD
Fludarabine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000365	0.000407	CcSEcCtD
Fludarabine—Chills—Epirubicin—peripheral nervous system neoplasm	0.00036	0.000401	CcSEcCtD
Fludarabine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00036	0.000401	CcSEcCtD
Fludarabine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000359	0.0004	CcSEcCtD
Fludarabine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000399	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	0.000356	0.00462	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GNS—peripheral nervous system neoplasm	0.000356	0.00462	CbGpPWpGaD
Fludarabine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000355	0.000395	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000355	0.0046	CbGpPWpGaD
Fludarabine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000353	0.000393	CcSEcCtD
Fludarabine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000391	CcSEcCtD
Fludarabine—Rash—Cisplatin—peripheral nervous system neoplasm	0.00035	0.00039	CcSEcCtD
Fludarabine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00035	0.00039	CcSEcCtD
Fludarabine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00035	0.000389	CcSEcCtD
Fludarabine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000348	0.000388	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000348	0.00452	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NME1—peripheral nervous system neoplasm	0.000341	0.00443	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—MYC—peripheral nervous system neoplasm	0.000335	0.00435	CbGpPWpGaD
Fludarabine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.000371	CcSEcCtD
Fludarabine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.00037	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.00033	0.00428	CbGpPWpGaD
Fludarabine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00033	0.000368	CcSEcCtD
Fludarabine—DCK—Metabolism—COX2—peripheral nervous system neoplasm	0.000328	0.00426	CbGpPWpGaD
Fludarabine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.000366	CcSEcCtD
Fludarabine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000324	0.000361	CcSEcCtD
Fludarabine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000324	0.00036	CcSEcCtD
Fludarabine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.00036	CcSEcCtD
Fludarabine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000323	0.00036	CcSEcCtD
Fludarabine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000358	CcSEcCtD
Fludarabine—Rash—Etoposide—peripheral nervous system neoplasm	0.000321	0.000357	CcSEcCtD
Fludarabine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000321	0.000357	CcSEcCtD
Fludarabine—Headache—Etoposide—peripheral nervous system neoplasm	0.000319	0.000355	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—AURKA—peripheral nervous system neoplasm	0.000318	0.00413	CbGpPWpGaD
Fludarabine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000351	CcSEcCtD
Fludarabine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000349	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000312	0.00405	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—peripheral nervous system neoplasm	0.000309	0.00401	CbGpPWpGaD
Fludarabine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000305	0.00034	CcSEcCtD
Fludarabine—POLA1—S Phase—MYC—peripheral nervous system neoplasm	0.000305	0.00395	CbGpPWpGaD
Fludarabine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000337	CcSEcCtD
Fludarabine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000302	0.000337	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000302	0.00392	CbGpPWpGaD
Fludarabine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000334	CcSEcCtD
Fludarabine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000333	CcSEcCtD
Fludarabine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000331	CcSEcCtD
Fludarabine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000331	CcSEcCtD
Fludarabine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000331	CcSEcCtD
Fludarabine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000328	CcSEcCtD
Fludarabine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000325	CcSEcCtD
Fludarabine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000322	CcSEcCtD
Fludarabine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000288	0.00032	CcSEcCtD
Fludarabine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000318	CcSEcCtD
Fludarabine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000318	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—CHEK2—peripheral nervous system neoplasm	0.000285	0.0037	CbGpPWpGaD
Fludarabine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000316	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	0.000283	0.00367	CbGpPWpGaD
Fludarabine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000314	CcSEcCtD
Fludarabine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000312	CcSEcCtD
Fludarabine—RRM1—Metabolism—ENO2—peripheral nervous system neoplasm	0.00028	0.00364	CbGpPWpGaD
Fludarabine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000312	CcSEcCtD
Fludarabine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000279	0.000311	CcSEcCtD
Fludarabine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000307	CcSEcCtD
Fludarabine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000307	CcSEcCtD
Fludarabine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000307	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000274	0.00356	CbGpPWpGaD
Fludarabine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000303	CcSEcCtD
Fludarabine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000303	CcSEcCtD
Fludarabine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000296	CcSEcCtD
Fludarabine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000294	CcSEcCtD
Fludarabine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000294	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000264	0.00342	CbGpPWpGaD
Fludarabine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000292	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.00026	0.00029	CcSEcCtD
Fludarabine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000288	CcSEcCtD
Fludarabine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000288	CcSEcCtD
Fludarabine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000285	CcSEcCtD
Fludarabine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000284	CcSEcCtD
Fludarabine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000283	CcSEcCtD
Fludarabine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.00028	CcSEcCtD
Fludarabine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000251	0.00028	CcSEcCtD
Fludarabine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000276	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000274	CcSEcCtD
Fludarabine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000274	CcSEcCtD
Fludarabine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000272	CcSEcCtD
Fludarabine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000272	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000268	CcSEcCtD
Fludarabine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000264	CcSEcCtD
Fludarabine—RRM1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000237	0.00307	CbGpPWpGaD
Fludarabine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000262	CcSEcCtD
Fludarabine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000262	CcSEcCtD
Fludarabine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000259	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	0.000231	0.003	CbGpPWpGaD
Fludarabine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000256	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000254	CcSEcCtD
Fludarabine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000253	CcSEcCtD
Fludarabine—RRM1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000226	0.00293	CbGpPWpGaD
Fludarabine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000251	CcSEcCtD
Fludarabine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000251	CcSEcCtD
Fludarabine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000251	CcSEcCtD
Fludarabine—RRM1—Metabolism—TH—peripheral nervous system neoplasm	0.000223	0.00289	CbGpPWpGaD
Fludarabine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000242	CcSEcCtD
Fludarabine—DCK—Metabolism—ENO2—peripheral nervous system neoplasm	0.000216	0.0028	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000214	0.00278	CbGpPWpGaD
Fludarabine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000234	CcSEcCtD
Fludarabine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000232	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—BIRC5—peripheral nervous system neoplasm	0.000206	0.00268	CbGpPWpGaD
Fludarabine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000228	CcSEcCtD
Fludarabine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000225	CcSEcCtD
Fludarabine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000217	CcSEcCtD
Fludarabine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000217	CcSEcCtD
Fludarabine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000211	CcSEcCtD
Fludarabine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000208	CcSEcCtD
Fludarabine—DCK—Metabolism—BCHE—peripheral nervous system neoplasm	0.000182	0.00236	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000182	0.00236	CbGpPWpGaD
Fludarabine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000202	CcSEcCtD
Fludarabine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000201	CcSEcCtD
Fludarabine—Rash—Epirubicin—peripheral nervous system neoplasm	0.00018	0.0002	CcSEcCtD
Fludarabine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00018	0.0002	CcSEcCtD
Fludarabine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000199	CcSEcCtD
Fludarabine—RRM1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000178	0.00231	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000176	0.00228	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000174	0.00226	CbGpPWpGaD
Fludarabine—DCK—Metabolism—TH—peripheral nervous system neoplasm	0.000171	0.00222	CbGpPWpGaD
Fludarabine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000189	CcSEcCtD
Fludarabine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000187	CcSEcCtD
Fludarabine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000185	CcSEcCtD
Fludarabine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000185	CcSEcCtD
Fludarabine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000184	CcSEcCtD
Fludarabine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000175	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	0.000153	0.00199	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000149	0.00193	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GNAS—peripheral nervous system neoplasm	0.00014	0.00181	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000137	0.00178	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	0.000137	0.00178	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	0.000104	0.00135	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MYC—peripheral nervous system neoplasm	9.27e-05	0.0012	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TP53—peripheral nervous system neoplasm	7.61e-05	0.000988	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—AKT1—peripheral nervous system neoplasm	4.9e-05	0.000636	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AKT1—peripheral nervous system neoplasm	3.77e-05	0.00049	CbGpPWpGaD
